U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
SERPLULIMAB
INN  
Official Name English
serplulimab [INN]
Common Name English
IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL HLX10 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HLX10 .KAPPA.-CHAIN, DIMER
Common Name English
Serplulimab [WHO-DD]
Common Name English
HLX-10
Code English
HLX10
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 869822
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
FDA ORPHAN DRUG 829321
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
Code System Code Type Description
CAS
2231029-82-4
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
PRIMARY
FDA UNII
S3GQZ2K36V
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
PRIMARY
NCI_THESAURUS
C156738
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
PRIMARY
INN
11176
Created by admin on Sat Dec 16 14:26:27 GMT 2023 , Edited by admin on Sat Dec 16 14:26:27 GMT 2023
PRIMARY
ACTIVE MOIETY
SERPLULIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966